Atara Biotherapeutics News

Atara Biotherapeutics | DEFA14A: Others

Apr 26 16:25 ET

Atara Biotherapeutics | DEF 14A: Definitive information statements

Apr 26 16:21 ET

Atara Biotherapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 12 16:19 ET

Atara Biotherapeutics | 8-K: Current report

Mar 29 16:33 ET

Atara Biotherapeutics | 8-K: Atara Biotherapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Operational Progress

Mar 28 08:39 ET

Atara Biotherapeutics | 8-K: Current report

Feb 23 16:36 ET

Atara Biotherapeutics | 8-K: Current report

Jan 9 00:00 ET

Atara Biotherapeutics | 8-K: Current report

Jan 8 00:00 ET

Atara Biotherapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jan 3 00:00 ET

Atara Biotherapeutics | 8-K: Current report

Dec 20, 2023 16:30 ET

Atara Biotherapeutics | 8-K: Current report

Nov 8, 2023 21:16 ET

Atara Biotherapeutics | S-3: Registration statement for specified transactions by certain issuers

Nov 1, 2023 17:25 ET

Atara Biotherapeutics | 8-K: Current report

Nov 1, 2023 16:05 ET

Atara Biotherapeutics | 8-K: Atara Biotherapeutics Announces Expanded Global Tab-cel ® Partnership with Pierre Fabre Laboratories and Third Quarter 2023 Financial Results

Nov 1, 2023 08:35 ET

Atara Biotherapeutics | 8-K: Current report

Sep 19, 2023 18:19 ET

Atara Biotherapeutics | 8-K: Atara Biotherapeutics Announces Second Quarter 2023 Financial Results and Operational Progress

Aug 8, 2023 16:07 ET

Atara Biotherapeutics | 8-K: Current report

Jun 9, 2023 16:06 ET

Atara Biotherapeutics | 8-K: Current report

Jun 5, 2023 16:05 ET

Atara Biotherapeutics | 8-K: Current report

May 12, 2023 16:31 ET

Atara Biotherapeutics | 8-K: Atara Biotherapeutics Announces First Quarter 2023 Financial Results and Operational Progress

May 8, 2023 16:06 ET